| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.173.4.2500 |
| P698 | PubMed publication ID | 15294965 |
| P2093 | author name string | Yang Yang | |
| Ying Wang | |||
| Chen Dong | |||
| Zhaoxia Li | |||
| Durbaka V R Prasad | |||
| Thang Nguyen | |||
| Julie Duong | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2500-2506 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Murine B7-H3 is a negative regulator of T cells | |
| P478 | volume | 173 |
| Q36168870 | A novel monoclonal antibody against mouse B7-H3 developed in rats |
| Q35506243 | A novel subset of B7-H3+CD14+HLA-DR-/low myeloid-derived suppressor cells are associated with progression of human NSCLC. |
| Q38966400 | Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis |
| Q40277507 | An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo. |
| Q36185034 | B7 family molecules as regulators of the maternal immune system in pregnancy |
| Q36264994 | B7-H3 Augments Inflammatory Responses and Exacerbates Brain Damage via Amplifying NF-κB p65 and MAPK p38 Activation during Experimental Pneumococcal Meningitis |
| Q35660891 | B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets |
| Q36640287 | B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer |
| Q36288654 | B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome |
| Q35634896 | B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality |
| Q96230945 | B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma |
| Q34298906 | B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction |
| Q33703916 | B7-H3 overexpression in pancreatic cancer promotes tumor progression |
| Q92621557 | B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-κB pathway in primary Sjögren's syndrome |
| Q37589269 | B7-H3 participates in the development of Asthma by augmentation of the inflammatory response independent of TLR2 pathway |
| Q49352678 | B7-H3 promoted proliferation of mouse spermatogonial stem cells via the PI3K signaling pathway |
| Q46488093 | B7-H3 promoted sperm motility in humans |
| Q34389662 | B7-H3 promotes acute and chronic allograft rejection |
| Q35530644 | B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway |
| Q39427326 | B7-H3 role in the immune landscape of cancer |
| Q94453573 | B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors |
| Q34356712 | B7-h3 and its role in antitumor immunity |
| Q37169029 | B7H3 ameliorates LPS-induced acute lung injury via attenuation of neutrophil migration and infiltration |
| Q92637402 | B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma |
| Q28589424 | BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation |
| Q99237709 | CAR T Cell Therapy for Pediatric Brain Tumors |
| Q92245332 | CAR T cells for brain tumors: Lessons learned and road ahead |
| Q37058267 | Cancer prevention and therapy through the modulation of the tumor microenvironment |
| Q35032331 | Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma |
| Q44967011 | Circulating B7-H3(CD276) elevations in cerebrospinal fluid and plasma of children with bacterial meningitis |
| Q34658452 | Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go. |
| Q37424100 | Clinical importance of B7-H3 expression in human pancreatic cancer |
| Q33892988 | Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma |
| Q28743206 | Cloning and characterization of porcine 4Ig-B7-H3: a potent inhibitor of porcine T-cell activation |
| Q36919720 | Co-stimulatory and Co-inhibitory Pathways in Autoimmunity. |
| Q36998864 | Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family |
| Q83439316 | Comparative proteomic analysis of rat hepatic stellate cell activation: a comprehensive view and suppressed immune response |
| Q90460206 | Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab |
| Q59477539 | Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations |
| Q64051822 | Dendritic cell-associated B7-H3 suppresses the production of autoantibodies and renal inflammation in a mouse model of systemic lupus erythematosus |
| Q34004810 | Dendritic cell-regulatory T-cell interactions control self-directed immunity |
| Q38317327 | Differentiation and activation of equine monocyte-derived dendritic cells are not correlated with CD206 or CD83 expression. |
| Q34251011 | Downregulation of integrin β4 decreases the ability of airway epithelial cells to present antigens |
| Q97069731 | ERMAP is a B7 family-related molecule that negatively regulates T cell and macrophage responses |
| Q48341461 | Effects of B7-H3 on the inflammatory response and expression of MMP-9 in mice with pneumococcal meningitis |
| Q39742066 | Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites |
| Q85007104 | Enhancement of membrane B7-H3 costimulatory molecule but reduction of its soluble form in multiple sclerosis |
| Q36693276 | Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity |
| Q47106672 | Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma |
| Q35871253 | Expression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma |
| Q43136029 | Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases |
| Q33520828 | Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer |
| Q33787586 | Expression patterns and action analysis of genes associated with inflammatory responses during rat liver regeneration |
| Q64100514 | FcγR-Binding Is an Important Functional Attribute for Immune Checkpoint Antibodies in Cancer Immunotherapy |
| Q37227080 | Fine tuning the immune response through B7-H3 and B7-H4 |
| Q28585447 | Generation and characterization of B7-H4/B7S1/B7x-deficient mice |
| Q93055972 | Helicobacter pylori elicits B7H3 expression on gastric epithelial cells: Implications in local T cell regulation and subset development during infection |
| Q64973209 | Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis. |
| Q39274136 | Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response |
| Q80577057 | Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation |
| Q47572823 | Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function |
| Q33827752 | Inhibitors of B7-CD28 costimulation in urologic malignancies |
| Q36016292 | Inhibitory costimulation and anti-tumor immunity |
| Q37292542 | Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses |
| Q36229535 | Interleukin 25 promotes the initiation of proallergic type 2 responses. |
| Q38040302 | MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY. |
| Q41809391 | Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy |
| Q64916370 | Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a. |
| Q37864696 | Molecular mechanisms of T-cell tolerance. |
| Q37406926 | Murine b7-h3 is a co-stimulatory molecule for T cell activation |
| Q58554275 | Myeloid cell-like transcript 2 is related to liver inflammation and the pathogenesis of hepatitis B via the involvement of CD8T cell activation |
| Q39416195 | New B7 Family Checkpoints in Human Cancers |
| Q36228596 | New battlefields for costimulation |
| Q56889626 | Not All Immune Checkpoints Are Created Equal |
| Q28740426 | Origination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune system |
| Q93187702 | Overexpression of B7-H3 as an opportunity for targeted therapy in head and neck cancers |
| Q37697212 | Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer |
| Q35870682 | Pancreatic ductal adenocarcinoma: a review of immunologic aspects |
| Q54442353 | Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients. |
| Q55511990 | Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy. |
| Q36594694 | Preferential Induction of the T Cell Auxiliary Signaling Molecule B7-H3 on Synovial Monocytes in Rheumatoid Arthritis |
| Q37563260 | Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis |
| Q47150218 | Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis |
| Q53650887 | Reduced serum B7-H3 levels in patients with ankylosing spondylitis. |
| Q34984502 | Regulation of T cell activation and tolerance by PDL2 |
| Q92799074 | Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma |
| Q38731474 | Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma. |
| Q37352797 | Senescence-associated exosome release from human prostate cancer cells. |
| Q34615333 | Single-nucleotide polymorphisms in the B7H3 gene are not associated with human autoimmune myasthenia gravis |
| Q40025345 | Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum |
| Q37721055 | Structure and T cell inhibition properties of B7 family member, B7-H3. |
| Q89685712 | T lymphocyte-targeted immune checkpoint modulation in glioma |
| Q38103582 | T-cell tolerance in cancer |
| Q34676739 | T-cell tolerance or function is determined by combinatorial costimulatory signals |
| Q36944386 | The B7 family and cancer therapy: costimulation and coinhibition |
| Q21184159 | The B7 family of immune-regulatory ligands |
| Q38304438 | The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy |
| Q36308080 | The Expression of B7-H3 Molecule in Periodontal Disease |
| Q36802534 | The contrasting role of B7-H3. |
| Q38684886 | The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1. |
| Q92618860 | The expressions and significance of B7-H3 and CTLA-4 in the clinical stages of non-small-cell lung cancer |
| Q24675388 | The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta |
| Q36290302 | The many sounds of T lymphocyte silence. |
| Q38085577 | The nature of activatory and tolerogenic dendritic cell-derived signal II. |
| Q35928357 | The role of coinhibitory signaling pathways in transplantation and tolerance |
| Q39160982 | The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3. |
| Q36141341 | Tissue biomarkers for prostate cancer radiation therapy |
| Q24316331 | Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses |
| Q34291894 | Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas |
| Q37461786 | Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma |
| Q90703788 | Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy |
| Q41851335 | Upregulation of the B7/CD28 family member B7-H3 in bladder cancer |
| Q39181190 | VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy |
| Q33872168 | Yin-Yang of costimulation: crucial controls of immune tolerance and function |
| Q89697863 | miRNAs as Key Players in the Management of Cutaneous Melanoma |
Search more.